Insights into the role of interferon lambda in hepatitis C virus infection

被引：6

作者：

Barth, Heidi ^{[1
,2
]}

机构：

[1] INSERM, U748, F-67000 Strasbourg, France

[2] Univ Strasbourg, F-67081 Strasbourg, France

来源：

JOURNAL OF HEPATOLOGY | 2011年 / 54卷 / 05期

关键词：

GENETIC-VARIATION; EXPRESSION; RIBAVIRIN; IL28B; REPLICATION; CLEARANCE; THERAPY; ALPHA; CELLS;

D O I：

10.1016/j.jhep.2010.10.008

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：844 / 847

页数：4

共 22 条

[1] Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection [J].

Chen, LM ;

Borozan, I ;

Feld, J ;

Sun, J ;

Tannis, LL ;

Coltescu, C ;

Heathcote, J ;

Edwards, AM ;

McGilvray, ID .

GASTROENTEROLOGY, 2005, 128 (05) :1437-1444

[2] Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes [J].

Doyle, Sean E. ;

Schreckhise, Heidi ;

Khuu-Duong, Kien ;

Henderson, Katherine ;

Rosler, Robert ;

Storey, Harold ;

Yao, Lena ;

Liu, Hong ;

Barahmand-pour, Fariba ;

Sivakumar, Pallavur ;

Chan, Chung ;

Birks, Carl ;

Foster, Don ;

Clegg, Christopher H. ;

Wietzke-Braun, Perdita ;

Mihm, Sabine ;

Klucher, Kevin M. .

HEPATOLOGY, 2006, 44 (04) :896-906

[3] Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response [J].

Feld, Jordan J. ;

Nanda, Santosh ;

Huang, Ying ;

Chen, Weiping ;

Cam, Maggie ;

Pusek, Susan N. ;

Schweigler, Lisa M. ;

Theodore, Dickens ;

Zacks, Steven L. ;

Liang, T. Jake ;

Fried, Michael W. .

HEPATOLOGY, 2007, 46 (05) :1548-1563

[4] Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance [J].

Ge, Dongliang ;

Fellay, Jacques ;

Thompson, Alexander J. ;

Simon, Jason S. ;

Shianna, Kevin V. ;

Urban, Thomas J. ;

Heinzen, Erin L. ;

Qiu, Ping ;

Bertelsen, Arthur H. ;

Muir, Andrew J. ;

Sulkowski, Mark ;

McHutchison, John G. ;

Goldstein, David B. .

NATURE, 2009, 461 (7262) :399-401

[5] Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C [J].

Honda, Masao ;

Sakai, Akito ;

Yamashita, Tatsuya ;

Nakamoto, Yasunari ;

Mizukoshi, Eishiro ;

Sakai, Yoshio ;

Yamashita, Taro ;

Nakamura, Mikiko ;

Shirasaki, Takayoshi ;

Horimoto, Katsuhisa ;

Tanaka, Yasuhito ;

Tokunaga, Katsushi ;

Mizokami, Masashi ;

Kaneko, Shuichi .

GASTROENTEROLOGY, 2010, 139 (02) :499-509

[6] Course and outcome of hepatitis C [J].

Hoofnagle, JH .

HEPATOLOGY, 2002, 36 (05) :S21-S29

[7] IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex [J].

Kotenko, SV ;

Gallagher, G ;

Baurin, VV ;

Lewis-Antes, A ;

Shen, ML ;

Shah, NK ;

Langer, JA ;

Sheikh, F ;

Dickensheets, H ;

Donnelly, RP .

NATURE IMMUNOLOGY, 2003, 4 (01) :69-77

[8] A look behind closed doors: interaction of persistent viruses with dendritic cells [J].

Lambotin, Melanie ;

Raghuraman, Sukanya ;

Stoll-Keller, Francoise ;

Baumert, Thomas F. ;

Barth, Heidi .

NATURE REVIEWS MICROBIOLOGY, 2010, 8 (05) :350-360

[9] Interferon-lambda serum levels in hepatitis C [J].

Langhans, Bettina ;

Kupfer, Bernd ;

Braunschweiger, Ingrid ;

Arndt, Simone ;

Schulte, Wibke ;

Nischalke, Hans Dieter ;

Nattermann, Jacob ;

Oldenburg, Johannes ;

Sauerbruch, Tilman ;

Spengler, Ulrich .

JOURNAL OF HEPATOLOGY, 2011, 54 (05) :859-865

[10] Interferons α and λ inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics [J].

Marcello, Tobias ;

Grakoui, Arash ;

Barba-Spaeth, Giovanna ;

Machlin, Erica S. ;

Kotenko, Sergei V. ;

MacDonald, Margaret R. ;

Rice, Charles M. .

GASTROENTEROLOGY, 2006, 131 (06) :1887-1898

← 1 2 3 →